Early versus delayed endocrine treatment of pN1-3 MO prostate cancer without local treatment of the primary tumor: Results of European organisation for the research and treatment of cancer 30846 - A phase III study

Journal of Urology

Volumn 172, Issue 3, 2004, Pages 923-927

  Schröder, Fritz H ^a   Kurth, Karl Heinz ^b   Fosså, Sophie D ^e   Hoekstra, Wytze ^d   Karthaus, Peter P M ^c   Debois, Muriel ^f   Collette, Laurence ^f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^d Medicenter   (Netherlands)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f European Organisation of Research and Treatment of Cancer   (Belgium)

Author keywords

Androgen antagonists; Lymph nodes; Neoplasm metastasis; Prostate; Prostatic neoplasms

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; GONADORELIN AGONIST; GOSERELIN;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER RESEARCH; CANCER SURVIVAL; CASTRATION; CHRONOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELAYED TREATMENT; DRUG EFFECT; EARLY TREATMENT; EUROPEAN ORGANIZATION FOR THE RESEARCH AND TREATMENT OF CANCER 30846; FOLLOW UP; HAZARDS RATIO; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STATISTICAL POWER;

EID: 4143086051     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000135742.13171.d2     Document Type: Article

References (15)

1. Mellinger, G. T. and Blackard, C.: The incidence of cardiovascular complications in prostate cancer. In: Life Sciences Monographs 1. Edited by G. Raspé. Vieweg: Pergamon Press, pp. 65-76, 1969
2. Byar, D. P.: VACURG studies on prostatic cancer and its treatment. In: Urologic Pathology: The Prostate. Edited by M. Tannenbaum. Philadelphia: Lea & Febiger, pp. 241-267, 1977
3. Kramer, S. A., Cline, W. A., Jr., Farnham, R., Carson, C. C., Cox, E. B., Hinshaw, W. et al: Prognosis of patients with stage D1 prostatic adenocarcinoma. J Urol, 125: 817, 1981
4. van Aubel, O. G. J. M., Hoekstra, W. J. and Schröder, F. H.: Early orchiectomy for patients with stage D1 prostatic carcinoma. J Urol, 134: 292, 1985
5. Zincke, H., Flemming, T. R., Furlow, W. L., Myers, R. P. and Utz, D. C.: Radical retropubic prostatectomy and pelvic lymphadenectomy for high-stage cancer of the prostate. Cancer, 47: 1901, 1981
6. Whitmore, W. F., Jr.: Natural history and staging of prostate cancer. Urol Clin North Am, 11: 205, 1984
7. Freedman, L. S.: Tables of the number of patients required in clinical trials using the logrank test. Stat Med, 1: 121, 1982
8. Moher, D., Schulz, K. F. and Altman, D. G.: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet, 357: 1191, 2001
9. Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Prostate Cancer Trialists' Collaborative Group. Lancet, 355: 1491, 2000
10. Holmberg, L., Bill-Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Haggman, M. et al: A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med, 347: 781, 2002
11. Messing, E. M., Manola, J., Sarosdy, M., Wilding, G., Crawford, E. D. and Trump, D.: Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med, 341: 1781, 1999
12. Messing, E., Manola, J., Sarosdy, M., Wilding, G., Crawford, E. D. and Trump, D.: Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node positive prostate cancer: results at 10 years of EST 3886. J Urol, suppl., 169: 396, abstract 1480, 2003
13. Bolla, M., Collette, L., Blank, L., Warde, P., Dubois, J. B., Mirimanoff, R. O. et al: Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet, 360: 103, 2002
14. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group. Br J Urol, 79: 235, 1997
15. Kirk, D. on behalf of the Medical Research Council Prostate Cancer Working Party Investigators Group: Immediate versus deferred hormone treatment for prostate cancer: how safe is androgen deprivation? BJU Int, 86: 220, abstract MP6.1.07, 2000